Workup for Severe Hypertension (BP >200 mmHg) at Age 56: Evaluating for Renovascular Hypertension and Pheochromocytoma
For a 56-year-old with unexpectedly severe hypertension (BP >200 mmHg), immediately screen for pheochromocytoma with urinary fractionated metanephrines (the diagnostic test of choice) and evaluate for renovascular hypertension if clinical clues are present, particularly given the age and severity of presentation.
Immediate Diagnostic Approach
Pheochromocytoma Screening
Biochemical testing is the first step 1:
- Urinary fractionated metanephrines is the diagnostic test of choice (sensitivity 97-98%) 1
- Plasma free metanephrines achieves the highest sensitivity (97-98%) and specificity (85-89%), but is not routinely available 1, 2
- Very high values require no further testing before proceeding to imaging 1
When to suspect pheochromocytoma 3:
- Paroxysmal and/or severe sustained hypertension refractory to usual therapy
- Multiple symptoms of catecholamine excess: headaches, palpitations, sweating, panic attacks, pallor
- Hypertension triggered by beta-blockers or specific activities
- Incidentally discovered adrenal mass
If biochemical tests are positive, proceed to localization imaging 3:
- MRI is preferable (sensitivity >95%, specificity 100%) with high T2-weighted signal being highly characteristic 2
- CT with contrast if MRI unavailable (sensitivity 85-95%, specificity 70-100%) 2
Renovascular Hypertension Evaluation
Screen for renovascular hypertension if 2 or more clinical clues are present 4:
- Sudden onset or worsening of hypertension at age >55 years (this patient qualifies)
- Presence of abdominal bruit
- Hypertension resistant to 3 drugs
- Increase in serum creatinine ≥30% with ACE inhibitor or ARB use
- Other atherosclerotic vascular disease, particularly with smoking or dyslipidemia
- Recurrent pulmonary edema with hypertensive surges
Recommended screening tests 4, 5:
- Doppler ultrasound of renal arteries (first-line, non-invasive, no contrast needed) 5
- CT angiography (highly sensitive and specific)
- MR angiography (if eGFR >30 mL/min/1.73 m²) 4
- Captopril-enhanced radioisotope renal scan (only if eGFR >60 mL/min/1.73 m²) 4
Critical Pitfalls to Avoid
Do not start beta-blockers before alpha-blockade if pheochromocytoma is suspected 6, 7. Beta-blockers without adequate alpha blockade can precipitate hypertensive crisis.
Be aware that both conditions can coexist, though rare 8, 9, 10. If renovascular hypertension is confirmed but hypertension persists after intervention, reconsider pheochromocytoma. Elevated plasma renin activity does not exclude pheochromocytoma 9, 10.
For renovascular disease evaluation, avoid ACE inhibitors/ARBs in bilateral renal artery stenosis as they can cause acute renal function deterioration 1.
Algorithmic Workup Sequence
Obtain urinary fractionated metanephrines immediately (can be done while patient is on most antihypertensives)
Assess for renovascular hypertension clinical clues - this 56-year-old with BP >200 mmHg already meets age and severity criteria
If metanephrines elevated:
If renovascular clues present:
If both conditions suspected: Complete both workups as they can coexist, though this is uncommon 8, 9
Additional Essential Testing
- Basic metabolic panel (assess renal function, potassium for possible primary aldosteronism)
- Lipid panel (atherosclerotic risk assessment)
- Urinalysis and albumin-to-creatinine ratio
- ECG (assess for end-organ damage)
The severity of hypertension (>200 mmHg) at age 56 with no prior history mandates aggressive evaluation for secondary causes, as both pheochromocytoma and renovascular hypertension can cause significant cardiovascular morbidity and mortality if untreated, but are potentially curable with appropriate intervention 1, 4.